MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,094 Cr | ₹1,719 Cr | ₹1,513 Cr | ₹1,232 Cr | ₹1,037 Cr |
What is the latest Total Expenditure of MARKSANS PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹2,094 Cr |
| Mar2024 | ₹1,719 Cr |
| Mar2023 | ₹1,513 Cr |
| Mar2022 | ₹1,232 Cr |
| Mar2021 | ₹1,037 Cr |
How is Total Expenditure of MARKSANS PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,094 Cr | 21.84 | |
| Mar2024 | ₹1,719 Cr | 13.62 | |
| Mar2023 | ₹1,513 Cr | 22.80 | |
| Mar2022 | ₹1,232 Cr | 18.85 | |
| Mar2021 | ₹1,037 Cr | - | |
Compare Total Expenditure of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,391.7 Cr | -5.8% | -10.9% | -35.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -5.8% |
-10.9% |
-35.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses